Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase‐5A inhibitor vardenafil in rats with type 2 diabetes

AIMS: Heart failure with preserved ejection fraction (HFpEF) has a great epidemiological burden. The pathophysiological role of cyclic guanosine monophosphate (cGMP) signalling has been intensively investigated in HFpEF. Elevated levels of cGMP have been shown to exert cardioprotective effects in va...

Descripción completa

Detalles Bibliográficos
Autores principales: Mátyás, Csaba, Németh, Balázs T., Oláh, Attila, Török, Marianna, Ruppert, Mihály, Kellermayer, Dalma, Barta, Bálint A., Szabó, Gábor, Kökény, Gábor, Horváth, Eszter M., Bódi, Beáta, Papp, Zoltán, Merkely, Béla, Radovits, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2016
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347963/
https://www.ncbi.nlm.nih.gov/pubmed/27995696
http://dx.doi.org/10.1002/ejhf.711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347963/
https://www.ncbi.nlm.nih.gov/pubmed/27995696
http://dx.doi.org/10.1002/ejhf.711

Ejemplares similares